• A tradition of innovation
• Business Overview
• EDAP TMS worldwide
• Management

A tradition of innovation

EDAP TMS history and innovations in prostate cancer and urinary tract stones treatments.

Since it was founded in 1979, EDAP TMS has been committed to introducing new and innovative technologies for a minimally-invasive approach to treating urological disorders.
These proprietary technologies such as Focused Ultrasound or Piezo-electric shock waves have yielded new minimally invasive procedures for the treatment of several pathologies such as benign prostatic hyperplasia, localized prostate cancer or urinary tract stones.
EDAP TMS' design philosophy is to develop minimally-invasive devices for the benefit of the patient associating treatment efficacy and safety. The strength of EDAP TMS' R&D is to master mechanical, acoustic, electronic and IT technologies to produce state-of-the-art and ergonomic medical devices.

EDAP TMS's products are alternatives to traditional surgical procedures which often involve high cost, significant side effects and long recovery times.
Founded in 1979, the Company originally specialized in the manufacturing and distribution of ultrasound scanners and produced the first piezo-electric lithotripter in 1985. In 1994, the Company purchased most of the assets of Technomed International S.A. ("Technomed''). Technomed was established in 1985 and launched an electrohydraulic lithotripter in 1986 and the Prostatron, a medical device using TUMT (Transurethral Microwave Therapy) for the minimally-invasive treatment of Benign Prostate Hyperplasia (BPH), a non-cancerous urological condition.